Abstract
Although neurovascular compression of the cochlear nerve (NVC-C) presenting as typewriter tinnitus is a discrete disease category, verified diagnostic criteria are lacking. We sought to refine the diagnostic criteria for NVC-C by reference to a relatively large case series. The medical records of 22 NVC-C patients were retrospectively reviewed. Psychoacoustic characteristics, the results of diagnostic work-up (including audiovestibular neurophysiological tests and radiological evaluations), and the initial treatment response to carbamazepine were investigated. All subjects described their tinnitus as a typical “typewriter” or “staccato” sound. Of the 22 subjects, 11 (50%) had histories of vertiginous spells, but none had ipsilesional hearing loss. Vestibular function tests in 11 subjects tested revealed only 2 (18.2%) isolated cervical vestibular evoked myogenic potential abnormalities. Radiological comparisons of the symptomatic and asymptomatic sides, regarding the type of the vascular loop and neurovascular contact, revealed no significant differences. However, all 22 subjects exhibited immediate and marked responses to short-term carbamazepine treatment. Meticulous history-taking in terms of the psychoacoustic characteristics and the response to initial carbamazepine, are more reliable diagnostic clues than are radiological or neurophysiological data in NVC-C subjects. Therefore, the typical psychoacoustic characteristics and the response to initial carbamazepine should be included in the diagnostic criteria.
Introduction
An artery compressing a cranial nerve can stimulate that nerve, triggering hyperactive cranial nerve syndrome with or without loss of function. Examples of hyperactive disorders associated with microvascular compression include trigeminal neuralgia (the fifth cranial nerve), hemifacial spasms (the seventh nerve), and glossopharyngeal neuralgia (the ninth nerve).
In the time since Mardini first reported “ear-clicking tinnitus responding to carbamazepine”, the idea that neurovascular compression of the cochlear nerve (NVC-C) by the loop of the anterior-inferior cerebellar artery (AICA) is responsible for such typewriter tinnitus has become accepted1. Typewriter tinnitus is characterized by unilateral staccato tinnitus, described using the adjectives “typewriter”, “Morse code”, or “machine-gun”, and paroxysmal attacks with intermittent tinnitus-free intervals. While non-pulsatile subjective tinnitus is presume to be resulting from secondary functional changes in auditory or non-auditory brain areas2–8 and responds very poorly to almost all kinds of medical treatment, typewriter tinnitus responds very well to carbamazepine9–13.
Paroxysmal vertigo, also termed disabling positional vertigo, is assumed to be caused by compression of the vestibular part of the eighth cranial nerve by the loop of the AICA. Several terms have been coined to describe a group of audiovestibular symptoms including cochleovestibular nerve compression syndrome14 and cochleovestibular compression syndrome15. However, although NVC-C has long been regarded as a discrete disease category attributable to vascular compression of the eighth nerve, few verified diagnostic criteria are available. Furthermore, most previous studies focused on paroxysmal vertigo16–18; only a few case reports have explored typewriter tinnitus9, 12.
Thus, we evaluated the clinical characteristics, data from diagnostic work-ups (including audiovestibular neurophysiological tests and radiological evaluations), and the initial treatment responses in a relatively large group of patients with typewriter tinnitus. We propose refined diagnostic criteria for patients with NVC-C.
Materials and Methods
Subjects
The study protocol and a waiver of consent for retrospective chart review were approved by the institutional review board of the Clinical Research Institute at Seoul National Bundang Hospital (approval no. B-1608–360–101). All methods employed in this study were in accordance with the approved guidelines and the Declaration of Helsinki. Data were collected from an electronic medical records database. All personal information was kept confidential as required. All clinical data were retrospectively reviewed by two otologists. From January 2014 to November 2016, 28 patients were initially diagnosed with typewriter tinnitus at our tinnitus clinic. Detailed histories of tinnitus were obtained; the time of onset, the psychoacoustic nature of tinnitus, the affected side(s), and associated symptoms (e.g., paroxysmal vertigo or hemifacial spasms). All subjects visited the outpatient clinic of the department of otorhinolaryngology with typical symptoms of typewriter tinnitus (i.e., paroxysmal “typewriter”, “machine-gun”, or “crackling” sounds). Of the 28 patients, 1 with a cerebral infarction and 5 lost to follow-up were excluded from the study; thus, 22 subjects (5 males, 17 females) of mean age 51.2 ± 15.8 years (range, 23–84 years) were finally included. No patient had any history of neurological disease, a tumor in the internal acoustic canal (IAC) or cerebello-pontine angle (CPA), or temporal bone trauma.
Audiovestibular neurophysiological tests
The otoscopic findings and the pure tone audiometry (PTA) data of all patients were evaluated. The mean hearing level (MHL) was calculated as the average hearing threshold at 0.5, 1, 2, and 3 kHz19. Normal hearing was defined as an MHL ≤ the 25-decibel hearing level (dB HL).
For all patients presenting with typewriter tinnitus, vestibular function tests (VFTs), including the bithermal caloric test; recording of ocular vestibular evoked myogenic potentials (oVEMPs) and cervical VEMPs (cVEMPs); and the rotational chair test, were recommended at the initial visit. Of the 21 patients, 10 underwent at least one of these VFTs. Vestibular function was considered abnormal when: (1) canal paresis (CP, %; calculated using Jongkee’s formula) was > 25%20; or (2) when the VEMPs were reduced or absent on the affected side (oVEMP or cVEMP asymmetry ratio >40% or >33%, respectively21); or (3) when the slow harmonic acceleration (SHA) phase of the rotational chair test exhibited a reduced gain or an increased phase lead, in at least three consecutive frequencies of those tested (0.01, 0.02, 0.04, 0.08, 0.16, 0.32, and 0.64 Hz), using the manufacturer-provided normative data as references (Neuro Kinetics, Inc., Pittsburgh, PA, USA)22.
Radiological evaluation
All subjects presenting with typewriter tinnitus were recommended to undergo magnetic resonance imaging of the internal acoustic canal (IAC-MRI). Of the 21 subjects, 14 actually underwent this. Two neuro-radiologists blinded to the clinical findings separately evaluated the neurovascular features of the IAC and the cerebello-pontine angle (CPA) on axial, three-dimensional (3D), T2-weighted, volume, isotropic, turbo, spin-echo acquisition (T2-VISTA) sequences obtained via 3T-MRI, and made final decisions by consensus. The types of AICA loops were defined using the Chavda classification: Type I, the AICA loop lay within the CPA but did not enter the IAC; Type II, the AICA loop lay within <50% of the length of the IAC; and, Type III, the AICA loop extended into >50% of the IAC (Fig. 1)23. In addition, the types of neurovascular contact were classified into the following categories using the system of Gultekin et al.: Type I, no contact; Type II, vascular contact without angulation of the cochleovestibular nerve; and Type III, angulation of the cochleovestibular nerve caused by neurovascular compression (Fig. 2)24.
Response to initial treatment with carbamazepine
After excluding other possible pathological causes of the tinnitus by careful history-taking and otological/neurological examinations, all patients were prescribed carbamazepine as an initial empirical treatment. Oral carbamazepine was initiated at 200–400 mg/day by reference to body weight. When a definite response to carbamazepine was evident, the daily dose was adjusted to the minimum effective level (100 mg/day in most cases). Over a maximum period of 3 months, all patients were followed up by blood testing, including complete blood counts25, 26. No patient ceased treatment because of side effects such as leukopenia or thrombocytopenia. The responses to carbamazepine were divided into three categories: (1) no response (NR); (2) partial remission (PR) (marked or partial relief); and (3) complete remission (CR) (complete suppression of the tinnitus).
Statistical analysis
Data are presented as means ± standard deviations. Fisher’s exact test was used to compare the VFT results by the presence of vertigo. The types of AICA loops and the types of neurovascular contacts evident on MRI were compared between the symptomatic and asymptomatic sides using the linear-by-linear association test. Statistical significance was set at P < 0.05. All statistical analyses were performed with the aid of SPSS software (version 18.0; SPSS, Inc., Chicago, IL, USA).
Results
Demographic characteristics and principal complaints
The mean duration of tinnitus was 14.6 months (range, 2 weeks to 10 years). In total, 19 of the 22 patients (86.4%) had tinnitus histories <2 years, whereas the other 3 had tinnitus for >3 years. The tinnitus was unilateral in 21 patients and bilateral in 1 (case no. 9, Table 1). Of the 21 patients with unilateral tinnitus, the right ear was affected in 10 and the left in 11.
Table 1.
Case No. | Sex/Age | Side | Duration of history (months) | Vertigo | Hearing impairment, MHL (dB HL) | Facial spasm | Carbamazepine responsiveness | MRI findings | Vestibular dysfunction | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|
AICA loop typea | Contact typeb | Caloric, CP (%) | oVEMP/cVEMP | Rotational chair test | ||||||||
1 | F/31 | R | 0.75 | − | −, 3 | − | +, CR | I | III | N/A | N/A | N/A |
2 | F/52 | L | 0.5 | + | −, 16 | − | +, PR | II | I | −, 4 | −/+ | − |
3 | M/47 | L | 0.75 | + | −, 10 | + | +, PR | I | III | N/A | N/A | N/A |
4 | F/43 | R | 7 years | + | +, 45 | − | +, PR | I | II | −, 11 | −/− | − |
5 | F/58 | R | 3 | + | −/8 | − | +, PR | II | II | −, 17 | −/− | N/A |
6 | F/84 | L | 1 | − | +, 45 | − | +, PR | I | I | N/A | N/A | N/A |
7 | M/77 | L | 8 | − | +, 53 | + | +, PR | I | I | N/A | N/A | N/A |
8 | M/39 | L | 6 | − | −, 3 | − | +, PR | III | II | N/A | N/A | N/A |
9 | M/65 | R/L | 10 years | − | −, 21/+, 30 | + | +, PR | II, II | II, I | N/A | N/A | N/A |
10 | F/72 | L | 5 | + | +, 28 | − | +, PR | I | II | −, 0 | N/A | − |
11 | F/40 | L | 1 year | − | −, 5 | − | +, PR | I | I | N/A | N/A | N/A |
12 | F/51 | R | 2 | + | −, 8 | − | +, PR | N/A | N/A | −, 3 | N/A | − |
13 | F/56 | R | 2 years | − | −, 12 | − | +, PR | N/A | N/A | −, 4 | N/A | − |
14 | F/27 | R | 6 | − | −, 10 | − | +, PR | N/A | N/A | −, 4 | −/+ | − |
15 | F/56 | L | 4 | + | −, 3 | − | +, PR | I | II | −, 1 | −/− | N/A |
16 | F/23 | R | 1 | + | −, 0 | + | +, PR | I | I | −, 16 | −/− | − |
17 | F/66 | R | 2 | + | −, 8 | − | +, PR | N/A | N/A | N/A | N/A | N/A |
18 | M/45 | R | 6 | + | −, 5 | − | +, PR | N/A | N/A | N/A | −/− | N/A |
19 | F/34 | L | N/A | − | −, 6 | − | +, PR | N/A | N/A | N/A | N/A | N/A |
20 | F/49 | R | 1 | − | −, 18 | − | +, CR | N/A | N/A | N/A | N/A | N/A |
21 | F/54 | L | 1.5 | + | −, 14 | − | +, CR | II | III | N/A | N/A | N/A |
22 | F/58 | L | 1 year | − | −, 8 | + | +, PR | I | II | −, 13 | −/− | N/A |
MHL, mean hearing level, the average hearing threshold at 0.5, 1, 2, and 3 kHz; AICA, anterior-inferior cerebellar artery; CP, canal paresis; CR, complete remission; PR, partial remission; N/A, not available.
aThe type of AICA loop according to Chavda classification23.
bThe type of neurovascular contact according to Gultekin and colleagues’ classification24.
Eight patients (36.4%) complained of typewriter tinnitus without any other neurotologic symptoms, while the other 14 (63.6%) had combined neurotologic symptoms. That is, 3 patients had combined ipsilateral hemifacial spasm, 9 had vertigo, and 2 complained of both hemifacial spasm and vertigo. Of 22 patients, 5 had bilateral symmetric mild to moderate sensorineural hearing loss.
Hearing impairment
The MHL of all patients was 15.6 ± 14.9 dB HL on the affected side(s). However, in all five patients with SNHL (median: 45 dB HL, range: 28–53 dB HL), the differences in hearing thresholds at all frequencies were <15 dB HL between the ipsi- and contra-lesional sides, thus not meeting the criteria for asymmetric SNHL27. Of five patients with hearing impairment, one had typewriter tinnitus on both sides. In four patients with unilateral tinnitus, the MHL asymmetries between the two ears ranged from 1 to 8 dB HL.
Vestibular dysfunction
Of the 11 patients who underwent vestibular function tests, 2 (18.2%) exhibited abnormal results. Of the two cases of vestibular dysfunction, one (case 2) presented with vertigo. Two patients (cases 2 and 14) exhibited only isolated abnormal cVEMP results; amplitudes were reduced in the affected ears and asymmetry ratio was 51.9% and 47.9%, respectively. We found no association between the presence of vertigo and abnormal results on vestibular dysfunction testing (P = 1.00, Fisher’s exact test).
Response to carbamazepine
All 22 patients responded positively to carbamazepine: CR was achieved in 3 cases (13.6%) and PR in 19 (86.4%). No instance of NR was noted. All 11 patients with both typewriter tinnitus and paroxysmal vertigo exhibited improvements in both the tinnitus and the vertigo. However, when they stopped their medication for a few days, the symptoms recurred. Of five patients with hemifacial spasms, three (60%) reported improvements after carbamazepine treatment.
MRI findings
Of the 22 patients, 15 underwent neuroimaging evaluation. Of 16 symptomatic sides (thus including one patient with bilateral typewriter tinnitus), we recorded 10 instances of type I AICA loops (62.5%), 5 of type II loops (31.3%), and 1 of a type III loop (6.3%). Of the 14 AICA loops of the asymptomatic sides, 9 were classified as type I (64.3%), 3 as type II (21.4%), and 2 as type III (14.3%). The anatomical locations of the AICA loops in the IAC and CPA did not differ significantly by the presence or absence of typewriter tinnitus (P = 1.00, linear-by-linear association).
Type III neurovascular contact (compression with nerve angulation/indentation) was evident in 3 of 16 sides (18.8%) with typewriter tinnitus. One of 14 (7.1%) sides without tinnitus exhibited type III neurovascular contact. Such contact (without nerve angulation/indentation) was evident on seven (43.8%) symptomatic sides and six (42.9%) asymptomatic sides. Six (37.5%) symptomatic sides and seven (50%) asymptomatic sides exhibited no neurovascular contact. The type of neurovascular contact did not differ significantly between the symptomatic and asymptomatic sides (P = 0.439, linear-by-linear association). In addition, no vascular structure other than the AICA loop contacted the cochleovestibular nerve.
Discussion
We analyzed the clinical characteristics, the results of audiovestibular neurophysiological tests and radiologic evaluations, and the initial treatment response to carbamazepine, in a relatively large group of patients with typewriter tinnitus. All patients showed CR or marked responses to short-term carbamazepine treatment, but neither the audiovestibular nor the radiological examinations revealed consistent ipsilesional abnormalities at levels >50% except for the type of neurovascular contact (types II and III combined, 62.5%). In short, the most consistent findings were the response to carbamazepine, followed by abnormal ipsilesional radiological findings.
The suggested pathophysiology of typewriter tinnitus and the possible role played bycarbamazepine
As mentioned above, an artery compressing a cranial nerve may stimulate that nerve triggering hyperactive cranial nerve syndromes [i.e., trigeminal neuralgia (the trigeminal nerve), hemifacial spasms (the facial nerve), vestibular paroxysmia (the vestibular nerve), and typewriter tinnitus (the cochlear nerve)]. The precise pathophysiological mechanism of neurovascular compression syndrome remains controversial. Although histopathological data are lacking for most cases of the syndrome, several possible pathophysiologies have been suggested by those studying various microvascular conflict disorders. For example, trigeminal neuralgia has been suggested to reflect neurovascular compression of the trigeminal nerve in the cistern of the cerebello-pontine angle28, 29; an inflammatory reaction of the nerve trunk may induce ectopic activity and potentially cause spontaneous pain30. In addition, in patients with hemifacial spasms, vascular compression of the facial nerve has been suggested to cause focal demyelination, reorganization, and axonal hyperactivity triggering the spasmodic symptoms31, 32. Schwaber et al. studied the histopathology of the vestibular nerve and suggested that the vascular loop did not play a primary role in the development of vestibular paroxysmia, but rather applied pressure to, or otherwise triggered, an ectopic excitation focus33. In fact, vascular looping around the internal auditory meatus does not always compress the eighth cranial nerve34, and thus some authors have emphasized that “conflict”, rather than “compression”, is the correct term15.
Carbamazepine (5H-dibenz[b,f]azepine-5-carboxamide) is an anticonvulsant widely used to treat partial and generalized epilepsy. The anticonvulsant effects of carbamazepine are attributable to partial inhibition of voltage-gated sodium channel activity. Therefore, carbamazepine reduces the frequency of the action potential by retarding recovery of the voltage-gated sodium channel after inactivation35.
Carbamazepine has also been used to treat various non-epileptic neurological disorders. In particular, it has been shown to reduce ectopic discharges from injured nerves (again by blocking the sodium channel) in patients with various neurovascular compression syndromes. For example, carbamazepine is one of the most extensively studied drugs for the treatment of trigeminal neuralgia. It has been evaluated in randomized clinical trials and is considered as the first-line treatment of choice for trigeminal neuralgia25, 36, 37. In addition, carbamazepine has occasionally been reported to relieve hemifacial spasms38, 39. It is also evidently effective in most patients with vestibular paroxysmia, even at low doses (200–600 mg/d)40. As is also true of other neurovascular compression syndromes, several anecdotal reports on small numbers of patients have claimed that carbamazepine is effective in patients with typewriter tinnitus1, 9, 11, 12. Similarly, in the present study on a relatively large number of such patients, short-term carbamazepine treatment caused the symptoms to disappear or markedly improve in all subjects. We suggest that, as is true of other neurovascular compression syndromes, carbamazepine-mediated inhibition of the voltage-gated sodium channel may suppress ephaptic axonal transmission in the injured cochlear nerve, and thus alleviate typewriter tinnitus.
Revisiting the previous diagnostic criteria for NVC-C
Various criteria have been used to diagnose NVC-C; these include the characteristic psychoacoustic features of tinnitus and the associated symptoms. In addition to history-taking, Moller et al. developed neurophysiological criteria; auditory brainstem responses (ABR) were employed to diagnose NVC-C41. Radiological studies have also sought to define characteristic MRI findings of typewriter tinnitus9, 12.
In 2007, De Ridder et al. developed diagnostic criteria for cochleovestibular compression syndrome (CVCS), which are now widely accepted15. They are: (1) unilateral paroxysmal tinnitus; (2) co-existent ipsilateral symptoms including hemifacial spasms, otalgia, vertiginous spells, or hearing losses at tinnitus frequencies; (3) MRI findings evidencing vestibular conflict; and (4) abnormal ABR15.
The differential diagnosis of typewriter tinnitus includes short attacks of unilateral tinnitus. In addition to the previously suggested features of the condition (unilateral, paroxysmal, and short-lasting), we emphasized the “staccato” character of the complaint when evaluating the psychoacoustic characteristics. All subjects described their tinnitus as tapping, clicking, or crackling in nature. Although one patient presented with bilateral tinnitus, all other psychoacoustic characteristics were typical and the patient was thus included in our current case series. Although hemifacial spasms and trigeminal neuralgia can be diagnosed solely on the basis of unilateral paroxysmal characteristics including symptom-free intervals, the diagnosis of typewriter tinnitus is less straightforward. As tinnitus can present with various psychoacoustic characteristics, NVC-C presenting with typewriter tinnitus can only be diagnosed after all other possible causes of tinnitus have been ruled out. In a previous study on the surgical outcomes of microvascular decompression, less strict selection criteria were adopted and, as a result, >30% of cases did not respond to surgical treatment34. In this context, meticulous history-taking in terms of the psychoacoustic characteristics of the tinnitus is of utmost importance for patient evaluation and management planning.
Turning to the associated ipsilateral symptoms, 22.7% of our current patients had hemifacial spasms and 50% histories of vertiginous spells. As all five cases with hearing impairment presented with bilaterally symmetrical hearing thresholds, none of these patients seemed to have ipsilateral hearing loss driven only by NVC-C. In addition, the vestibular function tests yielded normal caloric or rotation chair data from all 11 subjects tested; only 2 (18.2%) exhibited isolated cVEMP abnormalities inadequate to allow diagnosis of ipsilateral vestibular dysfunction. As the facial, vestibular, and cochlear nerves lie close together in the internal auditory canal, NVC-C can trigger concomitant hemifacial spasms or vestibular paroxysmia. The presence of an accompanying neurovascular compression syndrome increases the possibility that NVC-C is the cause of tinnitus. However, we found that concomitant symptoms (other than paroxysmal vertigo) were rarely evident in subjects with NVC-C, in agreement with previous anecdotal findings in a small number of patients. Thus, none of the six patients studied by Levine and none of the four studied by Brantberg had any associated ipsilateral symptom9, 12.
In the current study, we evaluated the MRI data of 15 patients with typewriter tinnitus in terms of radiological evidence of NVC-C. We found that radiological findings suggestive of neurovascular compression of the cochlear nerve were not pathognomonic, but did aid in the diagnosis of typewriter tinnitus. Thus, according to the Chavda classification, 35.7% of asymptomatic sides had AICA loops that entered the IAC. Fifty percent of asymptomatic sides exhibited neurovascular contact with or without angulation/indentation. In previous studies, vascular loops in the CPA were frequently found in asymptomatic normal populations42, 43. Other studies found no significant association between tinnitus and any of the following variables: type of vascular loop, vascular contact, or angulation of the cochlear nerve23, 24. Thus, any role for MRI in the diagnosis of typewriter tinnitus may be more ancillary than salient. However, MRI is very useful to rule out other pathologies, such as lesions of the CPA and IAC.
Abnormal ABR, such as a reduced peak II amplitude and a prolongation of interpeak latency (IPL) between peaks I and III, have repeatedly been reported to be diagnostic for NVC-C15, 41, 44. Patients with short histories of the condition usually present with normal amplitudes and latencies, but, after 2 years of symptoms, the amplitude of peak II decreases15, 34. In the present study, 85.7% of patients had short histories of symptoms (≤1 year) and none of these patients exhibited hearing impairment. Thus, the ABR were not routinely evaluated.
Response to carbamazepine may be the most reliable diagnostic clue in subjects with NVC-C
All 22 subjects improved markedly when on short-term carbamazepine treatment. In terms of the associated symptoms, paroxysmal vertigo and the hemifacial spasms abated in 100% and 60% of patients, respectively. As also found in previous case reports, all patients exhibited prompt symptom improvement, within 2 weeks of the commencement of low-dose carbamazepine9, 12. As prior studies revealed that carbamazepine did not benefit other tinnitus patients45, 46, the prompt response to low-dose carbamazepine may be the most reliable diagnostic criterion of typewriter tinnitus. In addition, considering that the previously suggested diagnostic criteria afforded a diagnostic accuracy of <50% in our current case series, some typewriter tinnitus patients can be diagnosed only by meticulous history-taking in terms of the psychoacoustic characteristics of their tinnitus, and a positive response to low-dose carbamazepine. Therefore, responsiveness to low-dose carbamazepine should be the first-line diagnostic criterion for typewriter tinnitus. We thus suggest a new diagnostic criteria for NVC-C that modifies previously suggested diagnostic criteria15 (Table 2).
Table 2.
Consider diagnosis when paroxysmal, short-lasting tinnitus observed. |
a. Staccato character (tapping, clicking, or crackling in nature) |
b. Typically, unilateral, but bilateral involvement can also be seen. |
1. Responsiveness to low-dose carbamazepine (200–400 mg/day) |
a. Prompt tinnitus improvement (within 2 weeks) |
b. When the medication is stopped, the symptoms may recur. |
2. Associated ipsilateral symptoms |
a. Paroxysmal vertiginous spells |
b. Hemifacial spasms |
3. Supportive criteria – positive auditory evoked potential using Moller’s criteria41 |
a. Commonly normal before 2 years of symptoms |
b. Ipsilateral interpeak latency I-III ≥ 2.3 ms |
c. Reduced peak II amplitude <33% |
4. Exclusionary criteria for NVC-C |
a. Tumor of the cerebellopontine angle or internal auditory canal on MRI |
b. Demyelination disease on cerebral MRI |
5. Positive MRI for vascular conflict have no diagnostic specificity. |
Limitations of the current study, and proposed future studies
To the best of our knowledge, this is the first study to show that meticulous history-taking and the response to initial carbamazepine are more reliable diagnostic clues than the previously suggested diagnostic criteria in many typewriter tinnitus patients. However, our current study had certain limitations. First, as we have already acknowledged, we could not evaluate changes in the latency and amplitude of the ABR; these were not evaluated in most patients because their symptoms were of short duration. Future studies exploring the diagnostic utility of the ABR in a larger number of subjects varying in symptom duration are needed to verify our results. Second, although carbamazepine is known to be ineffective for most forms of tinnitus (as mentioned above)45, 46, some studies have reported small effects of carbamazepine in patients with chronic tinnitus47, 48. Future studies comparing typewriter tinnitus to conventional pure-tone or narrow-band-noise-like tinnitus in terms of the response to carbamazepine are therefore required.
In conclusion, we suggest that meticulous history-taking in terms of subjective psychoacoustic characteristics, and the response to initial carbamazepine, are more reliable diagnostic clues than are radiological or neurophysiological findings in patients with typewriter tinnitus. In other words, radiological or neurophysiological abnormalities are of limited diagnostic utility. Therefore, the typical psychoacoustic characteristics and the response to initial carbamazepine should be included in the previously suggested diagnostic criteria.
Acknowledgements
This work was supported by a grant from the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health & Welfare, Republic of Korea (grant number HI14C2264).
Author Contributions
Study concept and design: W.S., Y.J., Y.B., J.K. and J.S. Acquisition of data: W.S., Y.J., J.J., J.K. and J.S. Analysis and interpretation of data: W.S., Y.B., J.K. and J.S. Interpretation of imaging: W.S., J.J and Y.B. Drafting of the manuscript: W.S., Y.J. and Y.B. Critical revision of the manuscript for important intellectual content: W.S, J.J., J.K. and J.S. Statistical analysis: W.S., Y.B., J.J., J.K. and J.S. Study supervision: J.K. and J.S. All authors reviewed the manuscript.
Competing Interests
The authors declare that they have no competing interests.
Footnotes
Woongsang Sunwoo and Yung Jin Jeon contributed equally to this work.
Publisher's note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
References
- 1.Mardini M. Ear-clicking” tinnitus” responding to carbamazepine. The New England journal of medicine. 1987;317:1542–1542. doi: 10.1056/nejm198712103172418. [DOI] [PubMed] [Google Scholar]
- 2.Song JJ, et al. A Quantitative Electroencephalography Study on Cochlear Implant-Induced Cortical Changes in Single-Sided Deafness with Tinnitus. Front Hum Neurosci. 2017;11 doi: 10.3389/fnhum.2017.00210. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Kim SH, et al. Neural substrates predicting short-term improvement of tinnitus loudness and distress after modified tinnitus retraining therapy. Sci Rep. 2016;6 doi: 10.1038/srep29140. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Song JJ, Vanneste S, Schlee W, Van de Heyning P, De Ridder D. Onset-related differences in neural substrates of tinnitus-related distress: the anterior cingulate cortex in late-onset tinnitus, and the frontal cortex in early-onset tinnitus. Brain Struct Funct. 2015;220:571–584. doi: 10.1007/s00429-013-0648-x. [DOI] [PubMed] [Google Scholar]
- 5.Song JJ, Vanneste S, De Ridder D. Dysfunctional Noise Cancelling of the Rostral Anterior Cingulate Cortex in Tinnitus Patients. PLoS One. 2015;10 doi: 10.1371/journal.pone.0123538. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Kim K, et al. A novel method for device-related electroencephalography artifact suppression to explore cochlear implant-related cortical changes in single-sided deafness. J Neurosci Methods. 2015;255:22–28. doi: 10.1016/j.jneumeth.2015.07.020. [DOI] [PubMed] [Google Scholar]
- 7.Song JJ, Punte AK, De Ridder D, Vanneste S. & Van de Heyning, P. Neural substrates predicting improvement of tinnitus after cochlear implantation in patients with single-sided deafness. Hear Res. 2013;299:1–9. doi: 10.1016/j.heares.2013.02.001. [DOI] [PubMed] [Google Scholar]
- 8.Song JJ, De Ridder D, Schlee W, Van de Heyning P, Vanneste S. “Distressed aging”: the differences in brain activity between early- and late-onset tinnitus. Neurobiol Aging. 2013;34:1853–1863. doi: 10.1016/j.neurobiolaging.2013.01.014. [DOI] [PubMed] [Google Scholar]
- 9.Levine RA. Typewriter tinnitus: a carbamazepine-responsive syndrome related to auditory nerve vascular compression. ORL J Otorhinolaryngol Relat Spec. 2006;68:43–46. doi: 10.1159/000090490. [DOI] [PubMed] [Google Scholar]
- 10.Mathiesen T, Brantberg K. Microvascular decompression for typewriter tinnitus-case report. Acta Neurochir (Wien) 2015;157:333–336. doi: 10.1007/s00701-014-2324-1. [DOI] [PubMed] [Google Scholar]
- 11.Nam EC, Handzel O, Levine RA. Carbamazepine responsive typewriter tinnitus from basilar invagination. J Neurol Neurosurg Psychiatry. 2010;81:456–458. doi: 10.1136/jnnp.2009.173104. [DOI] [PubMed] [Google Scholar]
- 12.Brantberg K. Paroxysmal staccato tinnitus: a carbamazepine responsive hyperactivity dysfunction symptom of the eighth cranial nerve. J Neurol Neurosurg Psychiatry. 2010;81:451–455. doi: 10.1136/jnnp.2009.173732. [DOI] [PubMed] [Google Scholar]
- 13.Bae YJ, Jeon YJ, Choi BS, Koo JW, Song JJ. The Role of MRI in Diagnosing Neurovascular Compression of the Cochlear Nerve Resulting in Typewriter Tinnitus. AJNR Am J Neuroradiol. 2017;38:1212–1217. doi: 10.3174/ajnr.A5156. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Schwaber MK, Hall JW. Cochleovestibular nerve compression syndrome. I. Clinical features and audiovestibular findings. Laryngoscope. 1992;102:1020–1029. doi: 10.1288/00005537-199209000-00012. [DOI] [PubMed] [Google Scholar]
- 15.De Ridder D, Heijneman K, Haarman B, van der Loo E. Tinnitus in vascular conflict of the eighth cranial nerve: a surgical pathophysiological approach to ABR changes. Prog Brain Res. 2007;166:401–411. doi: 10.1016/S0079-6123(07)66039-7. [DOI] [PubMed] [Google Scholar]
- 16.Bertrand RA, Molina P, Hardy J. Vestibular syndrome and vascular anomaly in the cerebello-pontine angle. Acta Otolaryngol. 1977;83:187–194. doi: 10.3109/00016487709128832. [DOI] [PubMed] [Google Scholar]
- 17.McCabe BF, Harker LA. Vascular loop as a cause of vertigo. Ann Otol Rhinol Laryngol. 1983;92:542–543. doi: 10.1177/000348948309200602. [DOI] [PubMed] [Google Scholar]
- 18.Wiet RJ, Schramm DR, Kazan RP. The retrolabyrinthine approach and vascular loop. Laryngoscope. 1989;99:1035–1039. doi: 10.1288/00005537-198910000-00009. [DOI] [PubMed] [Google Scholar]
- 19.Monsell EM. New and revised reporting guidelines from the Committee on Hearing and Equilibrium. American Academy of Otolaryngology-Head and Neck Surgery Foundation, Inc. Otolaryngol Head Neck Surg. 1995;113:176–178. doi: 10.1016/S0194-5998(95)70100-1. [DOI] [PubMed] [Google Scholar]
- 20.Jongkees LB, Maas JP, Philipszoon AJ. Pract Otorhinolaryngol (Basel) 1962. Clinical nystagmography. A detailed study of electro-nystagmography in 341 patients with vertigo; pp. 65–93. [PubMed] [Google Scholar]
- 21.Su CH, Chen CM, Young YH. Differentiating cerebellopontine angle meningioma from schwannoma using caloric testing and vestibular-evoked myogenic potentials. J Neurol Sci. 2013;335:155–159. doi: 10.1016/j.jns.2013.09.020. [DOI] [PubMed] [Google Scholar]
- 22.Palomar-Asenjo V, Boleas-Aguirre MS, Sanchez-Ferrandiz N, Perez Fernandez N. Caloric and rotatory chair test results in patients with Meniere’s disease. Otol Neurotol. 2006;27:945–950. doi: 10.1097/01.mao.0000231593.03090.23. [DOI] [PubMed] [Google Scholar]
- 23.McDermott AL, Dutt SN, Irving RM, Pahor AL, Chavda SV. Anterior inferior cerebellar artery syndrome: fact or fiction. Clin Otolaryngol Allied Sci. 2003;28:75–80. doi: 10.1046/j.1365-2273.2003.00662.x. [DOI] [PubMed] [Google Scholar]
- 24.Gultekin S, et al. Vascular loops at the cerebellopontine angle: is there a correlation with tinnitus? AJNR Am J Neuroradiol. 2008;29:1746–1749. doi: 10.3174/ajnr.A1212. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Davis EH. Clinical trials of tegretol in trigeminal neuralgia. Headache. 1969;9:77–82. doi: 10.1111/j.1526-4610.1969.hed0901077.x. [DOI] [PubMed] [Google Scholar]
- 26.Killian JM, Fromm GH. Carbamazepine in the treatment of neuralgia. Use of side effects. Arch Neurol. 1968;19:129–136. doi: 10.1001/archneur.1968.00480020015001. [DOI] [PubMed] [Google Scholar]
- 27.Saliba I, Martineau G, Chagnon M. Asymmetric hearing loss: rule 3,000 for screening vestibular schwannoma. Otol Neurotol. 2009;30:515–521. doi: 10.1097/MAO.0b013e3181a5297a. [DOI] [PubMed] [Google Scholar]
- 28.Barker FG, 2nd, Jannetta PJ, Bissonette DJ, Larkins MV, Jho HD. The long-term outcome of microvascular decompression for trigeminal neuralgia. N Engl J Med. 1996;334:1077–1083. doi: 10.1056/NEJM199604253341701. [DOI] [PubMed] [Google Scholar]
- 29.Kondo, A. Follow-up results of microvascular decompression in trigeminal neuralgia and hemifacial spasm. Neurosurgery40, 46-51, discussion 51–42 (1997). [DOI] [PubMed]
- 30.Jensen, T. S. Anticonvulsants in neuropathic pain: rationale and clinical evidence. Eur J Pain6 Suppl A, 61–68, 10.1053/eujp.2001.0324 (2002). [DOI] [PubMed]
- 31.Nielsen VK. Pathophysiology of hemifacial spasm: I. Ephaptic transmission and ectopic excitation. Neurology. 1984;34:418–426. doi: 10.1212/WNL.34.4.418. [DOI] [PubMed] [Google Scholar]
- 32.Ruby JR, Jannetta PJ. Hemifacial spasm: ultrastructural changes in the facial nerve induced by neurovascular compression. Surg Neurol. 1975;4:369–370. [PubMed] [Google Scholar]
- 33.Schwaber MK, Whetsell WO. Cochleovestibular nerve compression syndrome. II. Vestibular nerve histopathology and theory of pathophysiology. Laryngoscope. 1992;102:1030–1036. doi: 10.1288/00005537-199209000-00013. [DOI] [PubMed] [Google Scholar]
- 34.Ryu H, Yamamoto S, Sugiyama K, Nozue M. Neurovascular compression syndrome of the eighth cranial nerve. What are the most reliable diagnostic signs? Acta Neurochir (Wien) 1998;140:1279–1286. doi: 10.1007/s007010050250. [DOI] [PubMed] [Google Scholar]
- 35.Gallelli, L. et al. in Medical Uses, Pharmacokinetics and Adverse effects (ed Luca Gallelli) Ch. 4, 69-83 (Nova Science, 2013).
- 36.Campbell FG, Graham JG, Zilkha KJ. Clinical trial of carbazepine (tegretol) in trigeminal neuralgia. J Neurol Neurosurg Psychiatry. 1966;29:265–267. doi: 10.1136/jnnp.29.3.265. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 37.Nicol CF. A four year double-blind study of tegretol in facial pain. Headache. 1969;9:54–57. doi: 10.1111/j.1526-4610.1969.hed0901054.x. [DOI] [PubMed] [Google Scholar]
- 38.Boghen DR, Lesser RL. Blepharospasm and Hemifacial Spasm. Curr Treat Options Neurol. 2000;2:393–400. doi: 10.1007/s11940-000-0037-7. [DOI] [PubMed] [Google Scholar]
- 39.Alexander GE, Moses H., 3rd Carbamazepine for hemifacial spasm. Neurology. 1982;32:286–287. doi: 10.1212/WNL.32.3.286. [DOI] [PubMed] [Google Scholar]
- 40.Brandt T, Strupp M, Dieterich M. Vestibular paroxysmia: a treatable neurovascular cross-compression syndrome. J Neurol. 2016;263(Suppl 1):S90–96. doi: 10.1007/s00415-015-7973-3. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 41.Moller MB, Moller AR, Jannetta PJ, Jho HD. Vascular decompression surgery for severe tinnitus: selection criteria and results. Laryngoscope. 1993;103:421–427. doi: 10.1002/lary.5541030410. [DOI] [PubMed] [Google Scholar]
- 42.Makins AE, Nikolopoulos TP, Ludman C, O’Donoghue GM. Is there a correlation between vascular loops and unilateral auditory symptoms? Laryngoscope. 1998;108:1739–1742. doi: 10.1097/00005537-199811000-00027. [DOI] [PubMed] [Google Scholar]
- 43.Reisser C, Schuknecht HF. The anterior inferior cerebellar artery in the internal auditory canal. Laryngoscope. 1991;101:761–766. doi: 10.1288/00005537-199107000-00012. [DOI] [PubMed] [Google Scholar]
- 44.Moller MB, Moller AR, Jannetta PJ, Jho HD, Sekhar LN. Microvascular decompression of the eighth nerve in patients with disabling positional vertigo: selection criteria and operative results in 207 patients. Acta Neurochir (Wien) 1993;125:75–82. doi: 10.1007/BF01401831. [DOI] [PubMed] [Google Scholar]
- 45.Marks NJ, Onisiphorou C, Trounce JR. The effect of single doses of amylobarbitone sodium and carbamazepine in tinnitus. J Laryngol Otol. 1981;95:941–945. doi: 10.1017/S0022215100091647. [DOI] [PubMed] [Google Scholar]
- 46.Donaldson I. Tegretol: a double blind trial in tinnitus. J Laryngol Otol. 1981;95:947–951. doi: 10.1017/S0022215100091659. [DOI] [PubMed] [Google Scholar]
- 47.She W, et al. Treatment of subjective tinnitus: a comparative clinical study of intratympanic steroid injection vs. oral carbamazepine. Med Sci Monit. 2009;15:PI35–39. [PubMed] [Google Scholar]
- 48.Hoekstra, C. E., Rynja, S. P., van Zanten, G. A. & Rovers, M. M. Anticonvulsants for tinnitus. Cochrane Database Syst Rev, CD007960, doi:10.1002/14651858.CD007960.pub2 (2011). [DOI] [PMC free article] [PubMed]